Biomarin Pharmaceutical
Presence
Biomarin Pharmaceutical is one of the...
Biomarin Pharmaceutical is a company listed under the stock ticker BMRN (US).
Executives
View the org chart displaying its 30 main executives
Most searched biographies at Biomarin Pharmaceutical
- Alexander Hardy, President and Chief Executive Officer (starts on ...
- Willard Dere, Director
- Robert Hombach, Director
Popular executive movements at Biomarin Pharmaceutical
- Cristin Hubbard will join the company as Chief Commercial Officer on May 10, 2024 (posted on March 8 2024).
- Jeff Ajer, Executive Vice President and Chief Commercial Officer, will leave the company on Jul. 1, 2024 (posted on January 14 2024).
- Mark Enyedy has joined the company as Director (posted on December 22 2023).
Click here to view some more movements at Biomarin Pharmaceutical
Create your alert
to follow the executive moves at Biomarin Pharmaceutical.
Pharmaceuticals
Biomarin Pharmaceutical has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Biomarin Pharmaceutical
- BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET
- New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
- BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
- BioMarin Scheduled to Participate in March Investor Conferences
- BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
- BioMarin to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Thursday, February 22, 2024, at 4:30pm ET
- BioMarin to Present ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) Data Highlighting Long-Term Durability at 2024 European Association for Haemophilia and Allied Disorders (EAHAD) Congress
- BioMarin Pharmaceutical Inc. - BioMarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, at 10:30 am PT / 1:30 pm ET, in San Francisco, CA
- BioMarin Pharmaceutical Inc. - News
- Page Not Found
- View more press releases Close
Social media about Biomarin Pharmaceutical
- Biomarin Pharmaceutical on Wikipedia, Google News & Yahoo Finance
- Biomarin Pharmaceutical on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Alexander Hardy 
Call Biomarin Pharmaceutical at +1 415...
